![](https://endpts.com/wp-content/uploads/2021/06/mf-FE.jpg)
AstraZeneca builds into China; Eli Lilly hit with 483; GSK’s new collaboration
Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more.
AstraZeneca and Taizhou National Medical …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.